Close
  Indian J Med Microbiol
 

Figure 8: Effect of pretreatment of mice with SCH233390 (0.05 mg/kg, intraperitoneal a dopaminergic D1 receptor antagonist) (a), haloperidol (0.2 mg/kg, intraperitoneal, a dopaminergic D2 receptor antagonist) (b) and prazosin (1 mg/kg, intraperitoneal α1-adrenergic antagonist) (c) on the anti-immobility effect of hispidulin in the forced swimming test. Data are presented as the mean ± standard error of the mean ** P < 0.01, in comparison to the vehicle-treated group, ns (not significant) compared with hispidulin (3 mg/kg) treated group

Figure 8: Effect of pretreatment of mice with SCH233390 (0.05 mg/kg, intraperitoneal a dopaminergic D1 receptor antagonist) (a), haloperidol (0.2 mg/kg, intraperitoneal, a dopaminergic D2 receptor antagonist) (b) and prazosin (1 mg/kg, intraperitoneal α1-adrenergic antagonist) (c) on the anti-immobility effect of hispidulin in the forced swimming test. Data are presented as the mean ± standard error of the mean ** <i>P</i> < 0.01, in comparison to the vehicle-treated group, ns (not significant) compared with hispidulin (3 mg/kg) treated group